Amar Gajjar: Our front-line infant medulloblastoma trial is now open to enrollment in Children's Minnesota
Photo taken from Amar Gajjar/Twitter

Amar Gajjar: Our front-line infant medulloblastoma trial is now open to enrollment in Children’s Minnesota

Amar Gajjar, Pediatric Neuro-Oncologist at St. Jude Children’s Research Hospital, shared on X:

“Our front-line infant medulloblastoma trial is now open to enrollment in Children’s Minnesota.”

Amar Gajjar: Our front-line infant medulloblastoma trial is now open to enrollment in Children's Minnesota

Read further.
Source: Amar Gajjar/X